Search results
Results from the WOW.Com Content Network
Eli Lilly and Company, doing business as Lilly, ... During Bryson's 20-month tenure, the company reported its first quarterly loss as a publicly traded company.
Yahoo Finance compiled a list of the biggest publicly traded companies in each state and Washington, D.C. based on market cap. ... Other biotech companies on the list include Indiana's Eli Lilly ...
Innovation continued at the company after it was made a publicly traded corporation in 1952; it developed Humulin, Merthiolate, Prozac, and many other medicines. [8] [35] According to Forbes, Eli Lilly and Company ranked as the 243rd-largest company in the world as of 2016, with sales of $20 billion and a market value of $86 billion .
Lilly is now up 32% year to date, with a market cap of $689.5 billion, meaning it would need to grow by 45% to get to $1 trillion. However, a look at Eli Lilly's recent results shows why that's ...
However, Eli Lily is a fast-growing company, with a price/earnings-to-growth ratio (PEG ratio) of only 0.5. PEGs under 1 are usually considered undervalued, so on that basis, the stock is inexpensive.
This listing is limited to those independent companies and subsidiaries notable enough to have their own articles in Wikipedia. Both going concerns and defunct firms are included, as well as firms that were part of the pharmaceutical industry at some time in their existence, provided they were engaged in the production of human (as opposed to veterinary) therapeutics.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Lilly currently trades at over 61 times forward earnings, certainly not cheap but also not as high as the stock traded earlier this year. It is always going to be a crucial company for the U.S ...